Lin-Yun Wan

Lin-Yun Wan has conducted landmark clinical trials demonstrating the quality-of-life benefits of integrating traditional Chinese medicine with standard lung cancer treatments, providing high-quality evidence for symptom management and treatment tolerance improvement. Her laboratory research on herbal anti-angiogenesis compounds has identified traditional medicines that modulate the tumor microenvironment through VEGF-independent mechanisms. She contributes to national clinical practice guidelines for TCM integration in thoracic oncology.